Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug candidates where the bromoethoxy group serves as a reactive handle for further functionalization. Its structure supports the introduction of fluorinated aromatic systems into larger molecules, enhancing metabolic stability and bioavailability. Commonly employed in medicinal chemistry for constructing kinase inhibitors and CNS-active compounds. Also utilized in agrochemical research for designing novel active ingredients with improved lipophilicity and target binding.